Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review

被引:0
作者
Gras-Martin, Laura [1 ,2 ,3 ]
Plaza-Diaz, Adrian [1 ,2 ]
Zarate-Tamames, Borja [1 ,2 ]
Vera-Artazcoz, Paula [2 ,3 ,4 ]
Torres, Olga H. [2 ,3 ,5 ]
Bastida, Carla [6 ,7 ]
Soy, Dolors [6 ,7 ]
Ruiz-Ramos, Jesus [1 ,2 ,3 ]
机构
[1] Hosp Santa Creu i St Pau, Pharm Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[2] Inst Recerca St Pau IR St PAU, Sat Quinti 77-79, Barcelona 08041, Spain
[3] Univ Autonoma Barcelona, Dept Med, Bellaterra 08193, Spain
[4] Hosp Santa Creu i St Pau, Intens Care Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[5] Hosp Samta Creu i St Pau, Internal Med Dept, Geriatr Unit, St Antoni Maria Claret 167, Barcelona 08025, Spain
[6] Hosp Clin Barcelona, Pharm Dept, Div Med, Villarroel 170, Barcelona 08036, Spain
[7] Univ Barcelona, Fac Pharm, Dept Pharmacol, Toxicol & Therapeut Chem, Ave de Joan XXIII 27-31, Barcelona 08028, Spain
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 09期
关键词
pharmacokinetics; pharmacodynamics; critically ill patients; antibiotic; exposure; target attainment; risk factors; RENAL REPLACEMENT THERAPY; CONTINUOUS VENOVENOUS HEMOFILTRATION; INTENSIVE-CARE-UNIT; LOW-EFFICIENCY DIALYSIS; PIPERACILLIN POPULATION PHARMACOKINETICS; VENTILATOR-ASSOCIATED PNEUMONIA; NEGATIVE BACTERIAL-INFECTIONS; ACUTE KIDNEY INJURY; CONTINUOUS-INFUSION; SEPTIC PATIENTS;
D O I
10.3390/antibiotics13090801
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
(1) Background: Knowledge about the behavior of antibiotics in critically ill patients has been increasing in recent years. Some studies have concluded that a high percentage may be outside the therapeutic range. The most likely cause of this is the pharmacokinetic variability of critically ill patients, but it is not clear which factors have the greatest impact. The aim of this systematic review is to identify risk factors among critically ill patients that may exhibit significant pharmacokinetic alterations, compromising treatment efficacy and safety. (2) Methods: The search included the PubMed, Web of Science, and Embase databases. (3) Results: We identified 246 observational studies and ten clinical trials. The most studied risk factors in the literature were renal function, weight, age, sex, and renal replacement therapy. Risk factors with the greatest impact included renal function, weight, renal replacement therapy, age, protein or albumin levels, and APACHE or SAPS scores. (4) Conclusions: The review allows us to identify which critically ill patients are at a higher risk of not reaching therapeutic targets and helps us to recognize the extensive number of risk factors that have been studied, guiding their inclusion in future studies. It is essential to continue researching, especially in real clinical practice and with clinical outcomes.
引用
收藏
页数:27
相关论文
共 309 条
[81]   Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis [J].
De Winter, Sabrina ;
van Hest, Reinier ;
Dreesen, Erwin ;
Annaert, Pieter ;
Wauters, Joost ;
Meersseman, Wouter ;
Van den Eede, Nele ;
Desmet, Stefanie ;
Verelst, Sandra ;
Vanbrabant, Peter ;
Peetermans, Willy ;
Spriet, Isabel .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021, 46 (05) :653-663
[82]  
Dedkaew T., 2015, INT J PHARM PHARM SC, V7, P232
[83]   Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox? [J].
Del Bono, Valerio ;
Giacobbe, Daniele Roberto ;
Marchese, Anna ;
Parisini, Andrea ;
Fucile, Carmen ;
Coppo, Erika ;
Marini, Valeria ;
Arena, Antonio ;
Molin, Alexandre ;
Martelli, Antonietta ;
Gratarola, Angelo ;
Viscoli, Claudio ;
Pelosi, Paolo ;
Mattioli, Francesca .
VIRULENCE, 2017, 8 (01) :66-73
[84]   Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED) [J].
Deshpande, Priya ;
Chen, Julie ;
Gofran, Anita ;
Murea, Marianna ;
Golestaneh, Ladan .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (08) :2632-2636
[85]   Therapeutic drug monitoring of β-lactam antibiotics in the ICU [J].
Dhaese, Sofie ;
Van Vooren, Sarah ;
Boelens, Jerina ;
De Waele, Jan .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (11) :1155-1164
[86]   Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study [J].
Dhaese, Sofie A. M. ;
Thooft, Alexander D. J. ;
Farkas, Andras ;
Lipman, Jeffrey ;
Verstraete, Alain G. ;
Stove, Veronique ;
Roberts, Jason A. ;
De Waele, Jan J. .
JOURNAL OF CRITICAL CARE, 2019, 52 :75-79
[87]   Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases [J].
Dimski, Thomas ;
Brandenburger, Timo ;
MacKenzie, Colin ;
Kindgen-Milles, Detlef .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2020, 43 (12) :753-757
[88]   Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumonia [J].
Dreesen, Erwin ;
Gijsen, Matthias ;
Elkayal, Omar ;
Annaert, Pieter ;
Debaveye, Yves ;
Wauters, Joost ;
Karlsson, Mats O. ;
Spriet, Isabel .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (09) :2479-2488
[89]   Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis [J].
Ehmann, Lisa ;
Zoller, Michael ;
Minichmayr, Iris K. ;
Scharf, Christina ;
Huisinga, Wilhelm ;
Zander, Johannes ;
Kloft, Charlotte .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (03) :309-317
[90]   Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study [J].
Ehmann, Lisa ;
Zoller, Michael ;
Minichmayr, Iris K. ;
Scharf, Christina ;
Maier, Barbara ;
Schmitt, Maximilian V. ;
Hartung, Niklas ;
Huisinga, Wilhelm ;
Vogeser, Michael ;
Frey, Lorenz ;
Zander, Johannes ;
Kloft, Charlotte .
CRITICAL CARE, 2017, 21